XML 92 R78.htm IDEA: XBRL DOCUMENT v3.22.1
Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Aug. 03, 2021
Feb. 06, 2020
Oct. 20, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
May 11, 2021
Apr. 12, 2021
Equity (Details) [Line Items]                
Proceeds from issuance     $ 108,737          
Net of issuance expenses     $ 509          
Total equity-based compensation expenses       $ 4,711 $ 3,987 $ 1,405    
Issuance of aggregate RSUs shares (in Shares) 24,222 173,005            
Compensation costs related to RSUs       1,130        
Total unrecognized compensation cost related to non-vested options       $ 10,369        
Weighted-average period       2 years 18 days        
Cash dividend per common share (in Dollars per share)               $ 0.37
Cash dividend total amount             $ 20,286  
2011 Plan [Member]                
Equity (Details) [Line Items]                
Total number of common shares available (in Shares)       8,000,000        
2021 Plan [Member]                
Equity (Details) [Line Items]                
Common shares available for future grant (in Shares)       1,868,172        
Employees and Directors [Member]                
Equity (Details) [Line Items]                
Weighted average grant date fair values of options granted (in Dollars per share)       $ 10.35 $ 7.99 $ 4.24    
Total intrinsic value of options exercised       $ 8,505 $ 11,658 $ 2,301    
IPO [Member]                
Equity (Details) [Line Items]                
Shares issued (in Shares)     3,898,304          
Shares issued price per share (in Dollars per share)     $ 29.5